Alamar Biosciences is a life-sciences company focused on precision proteomics for highly sensitive protein biomarker detection. Its automated platform is used in research areas such as immunology, neurology and oncology to find signals that conventional immunoassays may miss. Customers are primarily research and academic laboratories seeking earlier and more precise molecular readouts.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 13.1 | — | -7.7 | — |
| Q1 2026 | 26 | 98.9% | -21.3 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: HUTCHMED (China) Limited (HCM), Zenas BioPharma, Inc. (ZBIO), UroGen Pharma Ltd. (URGN), ADMA Biologics, Inc. (ADMA), Zymeworks Inc. (ZYME), Perdoceo Education Corporation (PRDO)